← Other lipid agents × lipids

TrialJournal of the American College of Cardiology2013

Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).

John R Guyton et al.PubMed ↗Full text ↗Publisher ↗

A later paper about NCT00120289. The trial’s primary report, PMID 22085343, speaks for it on the map; the numbers here are shown and do not vote.

What the trial testedas reported · 3,414 people · 2013

No range given

Reported lower lipids, no range given

−26%

Bigger than 6 in 10 on the map

As reported

HR 0.74, no interval

One number in the abstract

the abstract, start to end

… a trend toward benefit (hazard ratio: 0.74, p = 0.073).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Lipids
HR 0.74
Other lipid agentsLipids
1 / 3

54 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT00120289phase 33,414 enrolled2005a later paper about it
Full record →Abstract, authors, funding and every citing paper · PMID 23916935